Surgical Pathologist
Dr. Jay Mehta
Dr. Jay Mehta stands as a pioneer in diagnostic molecular pathology in India, conducting diverse molecular tests, including next-generation sequencing, for both solid and liquid tumors. As the first Indian pathologist to initiate PDL1 testing, he demonstrates a keen focus on biomarker testing for solid tumors. Dr. Mehta’s expertise extends to guest speaking engagements, where he adeptly addresses audiences of pathologists and medical oncologists, sharing insights on both solid and liquid tumor management.
Dr. Jay Mehta
Dr. Jay Mehta, President & Head of Neuberg Oncopath, is a distinguished surgical pathologist specializing in Oncopathology. Having completed his post-graduation at Tata Memorial Hospital, Mumbai, he possesses two decades of extensive experience in the field. Dr. Mehta’s expertise lies in diagnosing and analyzing cancerous tissues, contributing significantly to the field of Oncopathology. His leadership at Neuberg Oncopath underscores his commitment to providing high-quality diagnostic services in oncology.
- Oncopathology
- Medical Oncology